期刊
BIOMOLECULES
卷 13, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/biom13101464
关键词
gut-liver axis; 3-Indolepropionic acid; HSCs; liver fibrosis
In this study, it was found that 3-Indolepropionic acid (IPA) can directly activate hepatic stellate cells and promote the progression of liver fibrosis. IPA activates hepatic stellate cells by increasing reactive oxygen species (ROS) in mitochondria and the expression of inflammation-related genes. These findings reveal the mechanism by which IPA directly activates hepatic stellate cells through ROS-induced JNK and p38 signaling pathways.
There has been a growing interest in studying the communication of gut microbial metabolites between the gut and the liver as liver fibrosis progresses. Although 3-Indolepropionic acid (IPA) is regarded as a clinically valuable gut metabolite for the treatment of certain chronic diseases, the effects of oral administration of IPA on hepatic fibrosis in different animal models have been conflicting. While some mechanisms have been proposed to explain these contradictory effects, the direct impact of IPA on hepatic fibrosis remains unclear. In this study, we found that IPA could directly activate LX-2 human hepatic stellate cells in vitro. IPA upregulated the expression of fibrogenic marker genes and promoted the features associated with HSCs activation, including proliferation and contractility. IPA also increased reactive oxygen species (ROS) in mitochondria and the expression of inflammation-related genes in LX-2 cells. However, when a ROS-blocking agent was used, these effects were reduced. p38 and JNK, the downstream signaling cascades of ROS, were found to be required for the activation of LX-2 induced by IPA. These findings suggest that IPA can directly activate hepatic stellate cells through ROS-induced JNK and p38 signaling pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据